Roche Holding AG (RHHBY) News Headlines

▮ More

Date

Headline

10/18/2019 1:27:14 AM Roche: FDA Approves Xofluza To Treat Influenza In People With High Risk

10/18/2019 1:03:59 AM Roche Announces FDA Approval Of Xofluza

10/16/2019 1:14:18 AM Roche 9-month Sales Up 10%; Raises FY19 Outlook - Quick Facts

10/16/2019 1:01:06 AM Roche 9-months Group Sales Up 10% To CHF 46.1 Bln

10/14/2019 1:22:21 AM Genentech's Late-stage Study On Pemphigus Vulgaris Meets Primary Endpoint

10/14/2019 1:07:38 AM Genentech Says Phase III PEMPHIX Study Of Rituxan Meets Primary Endpoint

9/30/2019 10:57:52 AM Roche Presents Positive Phase III Results For Tecentriq-platinum-based Chemotherapy In Untreated Advanced Bladder Cancer

9/30/2019 3:36:59 AM FDA Approves First Drug To Treat Pediatric GPA And MPA

9/30/2019 2:36:19 AM Genentech To Report Positive Result From Single-arm Cohort Of Phase II/III BFAST

9/30/2019 1:32:28 AM Roche: FDA Approves Rituxan For Two Rare Blood Vessel Disorders In Children

9/30/2019 1:07:06 AM Roche Says FDA Approved Rituxan In Combination With Glucocorticoids

9/30/2019 1:06:00 AM Roche Extends Tender Offer For Shares Of Spark Therapeutics To Oct 30

9/27/2019 8:37:13 AM Roche : Tecentriq - Avastin Study Shows Encouraging Results In Unresectable HCC

9/27/2019 8:09:39 AM Roche To Present Results From Phase Ib Study Evaluating Tecentriq Plus Avastin

9/25/2019 2:09:27 AM CMA Invites Comments On Roche / Spark Transaction

9/23/2019 1:19:50 AM Roche To Present Results From Various Oncology Studies At ESMO - Quick Facts

9/23/2019 1:04:18 AM Roche Says Results From No. Of Studies Across Comprehensive Oncology Portfolio

9/20/2019 1:14:21 AM Roche: FDA Approves Cobas Babesia Test For Blood Donation Testing - Quick Facts

9/20/2019 1:03:14 AM Roche: FDA Approves Cobas Babesia Test For Use On Cobas 6800/8800 Systems

9/18/2019 1:10:57 AM Roche :FDA Grants Breakthrough Therapy Designation For Gazyva In Lupus Nephritis

Roche Holding Ag (RHHBY)